Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,700.00
Ask: 1,779.00
Change: 0.00 (0.00%)
Spread: 79.00 (4.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

Wed, 04th Nov 2020 10:38

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.

----------

FTSE 100 - WINNERS

----------

AstraZeneca, up 4.3%, Hikma, up 4.0% and GlaxoSmithKline, 2.6% higher. Pharmaceutical firms, often touted as defensive stocks, were on the up early on Wednesday following a volatile start for the FTSE 100 amid a tight and hard-to-call US election result. A "blue wave" sweep by Democrats might have brought more regulation for the pharmaceutical industry.

----------

FTSE 100 - LOSERS

----------

HSBC and Standard Chartered, down 3.4% and 5.2%. The two banking stocks were at the FTSE 100 on Wednesday morning, amid the political tensions in the US, giving back gains from Tuesday when they closed 4.3% higher and 3.9% higher, respectively.

----------

FTSE 250 - WINNERS

----------

Royal Mail, up 8.0%. The postal service provider surged after JPMorgan raised the stock to Overweight from Neutral.

----------

Marks & Spencer, up 4.8%. The retailer's interim performance was better than expected, despite swinging to a pretax loss of GBP87.6 million from a GBP158.8 million profit. Revenue for the six months to September declined 16% to GBP4.09 billion from GBP4.86 billion a year before.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Stobart Group, up 9.4%. The logistics, energy and aviation firm was hit by a reduction in passenger travel at Southend Airport. Revenue in the six months ended August dropped 29% to GBP53.2 million from GBP74.8 million, and Stobart's pretax loss ballooned to GBP77.4 million from GBP15.5 million. The company however, affirmed that it "remains focused on exiting Stobart Air" and is in talks with parties to dispose of its stake.

----------

Wishbone Gold, up 70%. The exploration firm said that geological consultants Terra Search spotted four magnetic targets, covering a total of 2.4 kilometres by 400 metres, at the Patersons Range gold project in Australia. Wishbone added that it has completed due diligence to acquire the project and will now move towards closing the acquisition.

----------

Gattaca, up 37%. The engineering and technology recruitment services firm said revenue slipped 15% in the year ended July 31 to GBP538.7 million from GBP634.3 million. Pretax profit fell 57% to GBP1.4 million from GBP3.4 million. But notes it will carry out an improvement plan which will see its Technology unit restructured. Adds that it will deliver GBP4 million in annual savings from costs during the year to November.

----------

CPL Resources, up 34% to 951.50 pence. The Dublin-based human resources firm has accepted a EUR317.8 million takeover from Outsourcing, a Tokyo-listed HR services provider. The EUR11.25 per share offer is a 36% premium to CPL closing price on Tuesday.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Tern, down 10%. The internet of things-focused investor announced a GBP860,000 investment to take a 23% stake in Talking Medicines, a provider of AI and machine learning services to the pharmaceutical industry.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.